hACE2 Protein (ECD)
€590.00
Price excl. shipping costs excl. VAT. For more information, see our shipping policy
SKU: P2020-016_100 trenzyme
Description
P2020-016: The human Angiotensin-Converting Enzyme 2 (hACE2) is a protein highly expressed at the surface of cells of the human lungs, arteries, kidney, heart and intestine and is shown to be the entry receptor for SARS-CoV-2 infection. The hACE2 protein is one of the most important components for Coronavirus research to develop effective therapies for COVID-19. Our recombinant human ACE2 protein (ECD, processed) and tag-free has high quality and is excellent for SARS-CoV2 R&D.
--
P2020-024: The human Angiotensin-Converting Enzyme 2 (hACE2) is a protein highly expressed at the surface of cells of the human lungs, arteries, kidney, heart and intestine and is shown to be the entry receptor for SARS-CoV-2 infection. The hACE2 protein is one of the most important components for Coronavirus research to develop effective therapies for COVID-19.
----
P2020-017: The human angiotensin-converting enzyme 2 (hACE2) has been shown to be the entry receptor for SARS-CoV-2 infection. Therefore, hACE2 protein is one of the most important components for Coronavirus research to develop effective therapies for COVID-19. Our high-quality biotinylated hACE2 protein (ECD) with Avi/His tag is ideal for SARS-CoV-2 research and development.
---
P2020-037: The hACE2 protein is among the most important components for coronavirus research to develop effective therapies for COVID-19, as it has been shown to be an entry receptor for SARS-CoV-2 infection hACE2 is highly expressed on tissue surfaces that have been shown to harbor SARS-CoV - these include the surface of cells of the human lung, arteries, kidneys, heart and intestine. Our non-biotinylated hACE Protein is made in Germany and shows high purity and quality.